VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
-1.07%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$303M
AUM Growth
-$17.4M
(-5.4%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-4.85%
Top 10 Holdings %
Top 10 Hldgs %
82.65%
Holding
26
New
4
Increased
1
Reduced
4
Closed
1
Top Buys
| 1 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$7.2M |
| 2 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
+$5.18M |
| 3 |
TMBR
Timber Pharmaceuticals, Inc.
TMBR
|
+$4.79M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$3.02M |
| 5 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
+$1.81M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
+$24.6M |
| 2 |
Regenxbio
RGNX
|
+$9.04M |
| 3 |
AGRX
Agile Therapeutics, Inc
AGRX
|
+$2.88M |
| 4 |
PTN
Palatin Technologies
PTN
|
+$148K |
| 5 |
KalVista Pharmaceuticals
KALV
|
+$7 |
Sector Composition
| 1 | Healthcare | 91.88% |